BACKGROUND: Retrospective postinfarction studies revealed that decreased heart rate turbulence (HRT) indicates increased risk for subsequent death. This is the first prospective study to validate HRT in a large cohort of the reperfusion era. METHODS AND RESULTS: One thousand four hundred fifty-five survivors of an acute myocardial infarction (age <76 years) in sinus rhythm were enrolled. HRT onset (TO) and slope (TS) were calculated from Holter records. Patients were classified into the following HRT categories: category 0 if both TO and TS were normal, category 1 if either TO or TS was abnormal, or category 2 if both TO and TS were abnormal. The primary end point was all-cause mortality. During a follow-up of 22 months, 70 patients died. Multivariately, HRT category 2 was the strongest predictor of death (hazard ratio, 5.9; 95% CI, 2.9 to 12.2), followed by left ventricular ejection fraction (LVEF) < or =30% (4.5; 2.6 to 7.8), diabetes mellitus (2.5; 1.6 to 4.1), age > or =65 years (2.4; 1.5 to 3.9), and HRT category 1 (2.4; 1.2 to 4.9). LVEF < or =30% had a sensitivity of 27% at a positive predictive accuracy level of 23%. The combined criteria of LVEF < or =30%, HRT category 2 or LVEF >30%, age > or =65 years, diabetes mellitus, and HRT category 2 had a sensitivity of 24% at a positive predictive accuracy level of 37%. The combined criteria of LVEF < or =30% or LVEF >30%, age > or =65 years, diabetes mellitus, and HRT category 1 or 2 had a sensitivity of 44% at a positive predictive accuracy level of 23%. CONCLUSIONS: HRT is a strong predictor of subsequent death in postinfarction patients of the reperfusion era.
BACKGROUND: Retrospective postinfarction studies revealed that decreased heart rate turbulence (HRT) indicates increased risk for subsequent death. This is the first prospective study to validate HRT in a large cohort of the reperfusion era. METHODS AND RESULTS: One thousand four hundred fifty-five survivors of an acute myocardial infarction (age <76 years) in sinus rhythm were enrolled. HRT onset (TO) and slope (TS) were calculated from Holter records. Patients were classified into the following HRT categories: category 0 if both TO and TS were normal, category 1 if either TO or TS was abnormal, or category 2 if both TO and TS were abnormal. The primary end point was all-cause mortality. During a follow-up of 22 months, 70 patients died. Multivariately, HRT category 2 was the strongest predictor of death (hazard ratio, 5.9; 95% CI, 2.9 to 12.2), followed by left ventricular ejection fraction (LVEF) < or =30% (4.5; 2.6 to 7.8), diabetes mellitus (2.5; 1.6 to 4.1), age > or =65 years (2.4; 1.5 to 3.9), and HRT category 1 (2.4; 1.2 to 4.9). LVEF < or =30% had a sensitivity of 27% at a positive predictive accuracy level of 23%. The combined criteria of LVEF < or =30%, HRT category 2 or LVEF >30%, age > or =65 years, diabetes mellitus, and HRT category 2 had a sensitivity of 24% at a positive predictive accuracy level of 37%. The combined criteria of LVEF < or =30% or LVEF >30%, age > or =65 years, diabetes mellitus, and HRT category 1 or 2 had a sensitivity of 44% at a positive predictive accuracy level of 23%. CONCLUSIONS: HRT is a strong predictor of subsequent death in postinfarction patients of the reperfusion era.
Authors: Juha S Perkiömäki; Sari Hämekoski; M Juhani Junttila; Vesa Jokinen; Jari Tapanainen; Heikki V Huikuri Journal: Ann Noninvasive Electrocardiol Date: 2010-07 Impact factor: 1.468
Authors: Beata Sredniawa; Sylwia Cebula; Jacek Kowalczyk; Velislav N Batchvarov; Agata Musialik-Lydka; Anna Sliwinska; Aleksandra Wozniak; Michal Zakliczynski; Marian Zembala; Zbigniew Kalarus Journal: Ann Noninvasive Electrocardiol Date: 2010-07 Impact factor: 1.468
Authors: Attila Makai; Anita Korsós; Péter Makra; Tamás Forster; György Abrahám; László Rudas Journal: Clin Auton Res Date: 2008-04 Impact factor: 4.435
Authors: Nathan M Segerson; Stephen L Wasmund; Moeen Abedin; Rakesh K Pai; Marcos Daccarett; Nazem Akoum; T Scott Wall; Richard C Klein; Roger A Freedman; Mohamed H Hamdan Journal: Heart Rhythm Date: 2006-11-01 Impact factor: 6.343
Authors: Alexander Berkowitsch; Wojciech Zareba; Thomas Neumann; Ali Erdogan; Scott Mc Nitt; Arthur J Moss; Heinz F Pitschner Journal: Ann Noninvasive Electrocardiol Date: 2004-07 Impact factor: 1.468